Site Search
Results
-
Integrating Environmental Data With Other Omics for Cancer Epidemiology - Workshop...
... Genomics is offering new possibilities for more targeted therapies and treatments for complex diseases, as well as new diagnostic methods. 10 Heterogeneity Heterogeneity in data ...
Size: 1.1MB https://www.niehs.nih.gov/sites/default/files/news/events/pastmtg/2023/environmental_data/integrating_environmental_data_workshop_report_508.pdf -
1994-01_Efactor Special Edition
... that can more readily translate laboratory-based findings into practical human therapies. ... of disease, and enable clinicians to prescribe appropriate intervention therapies. ...
Size: 3.3MB https://www.niehs.nih.gov/sites/default/files/2025-05/january_1994_508.pdf -
NAEHS Council Update - February 2024
... in Targeted Therapies, The University of Texas MD Anderson Cancer Center, Houston, TX . ... adult dermatomyositis (DM) and juvenile DM patients receiving immunosuppressive therapies. ...
Size: 331KB https://www.niehs.nih.gov/sites/default/files/DIR_February_2024_NAEHS_Council_Update_508.pdf -
Report of the Director, NIEHS - February 18-19, 2010
... SYMPOSIUM ON TARGETED ANTICANCER THERAPIES Bethesda, MD, March 4-6, 2010 The 8th International Symposium on Targeted Anticancer Therapies (TAT 2010) will cover the most promising ...
Size: 124KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/feb2010/report_of_the_director_niehs_feb2010_508.pdf -
February 2014 NAEHSC Meeting Minutes
... joining with NIH to study Alzheimer's disease, rheumatoid arthritis, and lupus, with the intent of distinguishing targets of the diseases most likely to respond to therapies. Dr. ...
Size: 1.6MB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/feb2014/february_2014_minutes_508.pdf -
NAEHS Council Update - May 2009
... Kyoto, Japan; and Novartis Pharma AG, Basel, Switzerland, studying the physiological functions of retinoid-related orphan receptors in immunity and discovery of potential therapies ...
Size: 227KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/may2009/division_of_intramural_research_naehs_council_update_may2009_508.pdf -
NIEHS Clinical Research Program - May 2009 Update
... as well as the development of clinical tools for assessment of innovative therapies. 9 Appendix 1. Components of the NIEHS Office of Human Research Regulatory Compliance ...
Size: 156KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/may2009/niehs_clinical_research_program_may2009_508.pdf -
NIEHS Office of Communications and Public Liaison (OCPL)
... protein tristetraprolin significantly reduced or protected mice from inflammation, which may lead to effective therapies. o Francesco DeMayo, Ph.D., of DIR, received tenure. . ...
Size: 1.4MB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/may2016/report_from_office_of_communications_and_public_liaison_508.pdf -
Division of Intramural Research - NAEHS Council Update - September 2014
... There is no other tool now available that is as simple, cheap, safe, and readily interpretable. 34 Adgent MA, Flake GP, Umbach DM, Stallings VA, Bernbaum JC, Rogan WJ. Urogenital ...
Size: 305KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/sep2014/sept_2014_naehs_council_update_dir_508.pdf -
Division of Intramural Research NAEHS Council Update, September 2015
... making this enzyme an important target for future cancer therapies and diagnostics. ... These findings might facilitate the design of therapies targeting specific forms of ...
Size: 238KB https://www.niehs.nih.gov/sites/default/files/about/boards/naehsc/agenda/sep2015/report_from_division_of_intramural_research_508.pdf
to Top